SCHEMBL4048607

SCHEMBL4048607

CN1CCN(c2nc3sc4c(Cl)ncnc4c3c3c2CCC(C)(C)C3)CC1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 13/20 0.64
PDE4A P27815 9/20 0.58
PDE4D Q08499 9/20 0.58
KDM4E B2RXH2 5/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 4/20 0.45
MAPT P10636 2/20 0.45
ADRB2 P07550 1/20 0.45
POLB P06746 2/20 0.44
OPRK1 P41145 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HSD17B10 Q99714 1/20 0.44
EEF2K O00418 1/20 0.43
LMNA P02545 1/20 0.43
AGTR1 P30556 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048395 0.92 PDE4B (0.62) PDE4BPDE4APDE4DKDM4EKMT2A
SCHEMBL4048329 0.90 PDE4B (0.56) PDE4BPDE4APDE4DKDM4EKMT2A
SCHEMBL4057386 0.89 PDE4B (0.69) PDE4BPDE4APDE4DKDM4EKMT2A
SCHEMBL4048665 0.83 KDM4E (0.56) PDE4BPDE4APDE4DKDM4EKMT2A
SCHEMBL4045956 0.81 PDE4B (0.57) PDE4BPDE4APDE4DKDM4EALDH1A1
SCHEMBL4046032 0.81 PDE4B (0.67) PDE4BPDE4APDE4DKDM4EKMT2A
SCHEMBL4047111 0.81 KDM4E (0.60) PDE4BPDE4APDE4DKDM4EKMT2A
SCHEMBL4045618 0.79 PDE4B (0.85) PDE4BPDE4APDE4DKDM4EKMT2A
SCHEMBL4046259 0.79 PDE4B (1.00) PDE4BPDE4APDE4DKDM4EALDH1A1
SCHEMBL4049204 0.79 POLB (0.51) PDE4BPDE4APDE4DKMT2AADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819710-B1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES ALMIRALL LAB (ES) 2009-03-11 EP disclosed
US-20090029955-A1 Pyridothienopyrimidine Derivatives ALMIRALL PRODESFARMA S.A. (ES) 2009-01-29 US disclosed
EP-1819710-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES Laboratorios Almirall, S.A. (ES) 2007-08-22 EP disclosed
WO-2006058724-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES LABORATORIOS ALMIRALL, S.A. (ES) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029955-A1 Pyridothienopyrimidine Derivatives PNPO, PDE4A, DPYD PDE4B 5/4885PDE4A 2/4885PDE4D 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.